Do Resveratrol and Dehydroepiandrosterone Increase Diminished Ovarian Reserve?

Creative Commons License

Özatik F. Y., Özatik O., Yiğitaslan S., Kaygısız B., Erol K.

EURASIAN JOURNAL OF MEDICINE, vol.52, no.1, pp.6-11, 2020 (ESCI, Scopus, TRDizin)

  • Publication Type: Article / Article
  • Volume: 52 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.5152/eurasianjmed.2019.19044
  • Journal Name: EURASIAN JOURNAL OF MEDICINE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.6-11
  • Keywords: Dehydroepiandrosterone, resveratrol, ovarian follicle, Vinylcyclohexene diepokside, ANTI-MULLERIAN HORMONE, 4-VINYLCYCLOHEXENE, OVOTOXICITY, EXPRESSION, APOPTOSIS, DAMAGE, CELLS, RATS, MICE, DHEA
  • Kütahya Health Sciences University Affiliated: Yes

Abstract

Objective: In this study, the aim is to observe changes induced by dehydroepiandrosterone (DHEA) and resveratrol (RES) in diminished ovarian follicles that was induced by 4-vinylcyclohexenediepoxide (VCD).